Each year, 100,000 people in the United States are diagnosed with a brain tumor. With his new book, Dr. Peter Black fills a gap in the lay readership, providing an accessible medical resource for adult patients and their families. Dr. Black, who has operated on more than 3,000 patients with brain tumors, is uniquely qualified to discuss both clinical treatment of and research into brain tumors. This invaluable resource tells patients everything they need to know to understand and address their diagnosis, in a four-part structure: &#8226; &#8220;What is a Brain Tumor?' provides straightforward information about how brain tumors are diagnosed, the different types of tumors and how they develop, and where to go for treatment. &#8226; &#8220;Coping with Shock&#8221; addresses the emotional impact of the diagnosis on the patient and their family, offering specific advice on support groups and how to managing work and finances during your treatment. &#8226; &#8220;Treatment options' outlines the complex array of available treatments in a sequential, logical, and thorough manner, enabling readers to make informed decisions. &#8226; &#8220;Recovery' describes how to deal with the aftermath, addressing issues ranging from physical scars to speech and occupational therapy. Dr. Black believes that more than half of brain tumor cases can be resolved with relatively minor side effects or none at all. Equipped with this informative book, patients and their family and friends can learn how to fight brain tumors effectively, putting them on the path to wellness.
Providing readily accessible information and real-world encouragement to people living with primary and metastatic brain tumors, this book discusses the basics of brain tumors, types of tumors, management of different tumors, related symptoms, treatments and side effects, the role of medical team members, and coping strategies from initial diagnosis throughout the course of the illness. At the same time, it also offers practical suggestions on symptom management and lifestyle modification, as well as real-life anecdotes and advice from both patients and family members and friends who are experiencing this diagnosis. Written by two experts working with a professional writer, as well as advice from other professionals, the book is crystal clear and easy to use. Balancing the uncertainties of prognosis with hope, Navigating Life with a Brain Tumor is an authoritative, realistic, yet compassionate guide to living with brain cancer.
Erscheinungsdatum: 02/2009, Medium: Taschenbuch, Einband: Kartoniert / Broschiert, Titel: Tumor Therapy Monitoring with Diffuse OpticalSpectroscopies, Titelzusatz: Preclinical and Clinical Applications, Autor: Sunar, Ulas, Verlag: VDM Verlag, Sprache: Englisch, Rubrik: Medizin // Allgemeines, Lexika, Seiten: 136, Informationen: Paperback, Gewicht: 219 gr, Verkäufer: averdo
Erscheinungsdatum: 01/2012, Medium: Taschenbuch, Einband: Kartoniert / Broschiert, Titel: On Tumor Growth with Limited Supply, Titelzusatz: Dynamical Systems Approach, Autor: Katz, Natan, Verlag: LAP Lambert Academic Publishing, Sprache: Englisch, Rubrik: Mathematik // Sonstiges, Seiten: 64, Informationen: Paperback, Gewicht: 112 gr, Verkäufer: averdo
Erscheinungsdatum: 30.06.2014, Medium: Taschenbuch, Einband: Kartoniert / Broschiert, Titel: Blessed with a Brain Tumor, Titelzusatz: Realizing It's All Gift and Learning to Receive, Autor: Will, Pye, Verlag: William Pye, Sprache: Englisch, Schlagworte: BIOGRAPHY & AUTOBIOGRAPHY // Personal Memoirs, Rubrik: Belletristik // Biographien, Erinnerungen, Seiten: 268, Informationen: Paperback, Gewicht: 277 gr, Verkäufer: averdo
Frontmatter -- Preface -- Contents -- List of Contributors -- List of Invited Active Participants -- 1. Methods for Detection of Tumor-Specific Sensitized Lymphocytes -- 1.1 Tumor-Specific and Cell-Mediated Immune Reactions Expressed in Pathomorphological Findings / Grundmann, E. -- 1.2 Problems in Identifying Tumor-Specific Sensitized Lymphocytes / Bansal, S. C. -- 1.3 The Mixed Lymphocyte Tumor Cell Culture (MLTC) Test: Review of a Method / Nagel, G. A. / Nagel, E. / Albrecht, R. / Bauder, E. L. -- 1.4 Lymphocyte Tansformation in Malignant Diseases. Communication I: Méthodologie Problems / Pappas, A. / Scheurlen, P. G -- 1.5 Microcytotocicity Test for Detection of Cellular Immunity to Nephroblastoma in Man / Diehl, V. -- 1.6 Comparative Tumorimmunological Studies with the Microcytotoxicity Test and the DNA-Synthesis Inhibition Test / Warnatz, H. -- 1.7 The Leukocyte Adherence Inhibition Test for Detection of Tumor-Specific Sensitized Lymphocytes and Serum Blocking Factors / Lampert, F. / Dietmair, E. -- 2. Methods for Detection of Molecular Antibodies against Tumor Proteins -- 2.1 A Special Aspect of the Complement Fixation Test Applied to the Study of Tumors / Lovisetto, P. / Guarini, G. / Molfese, G. / Biarese, V. -- 2.2 Principle and Technique of the &#8222;Lewis-3 D Test' for the Serological Diagnosis of Malignancy - A Critical Evaluation of the Results / Schneider, C. C. / Uebel, H. -- 3. Methods for Detection of Tumor Cell Surface Antigens -- 3.1 The Preparation and Application of Hybrid Antibody for the Detection of Tumor-Specific Cell Surface Antigens / Gelderblom, H. -- 3.2 In vitro Characterization of Avian Oncornavirus Directed Tumor Antigens / Kurth, R. / Gelderblom, H. / Bauer, H. -- 3.3 Tumor-Cell Membrane Antigens Related to Blood Group A Substances / Prokop, O. / Rothe, A. / Uhlenbruck, G. -- 3.4 Erythrocytic ABH-Receptors in Leukemia - An Immunofluorescence Study / Fischer, K. / Poschmann, A. -- 3.5 Immunological Aspects of Placental Choriocarcioma / Robinson, E. -- 4. Methods for Detection of Non Tumor Antigens and Fetal Proteins -- 4.1 Non Tumor Antigens in Human Tumors / Koldovsky, P. / Weinstein, J. / Lischner, H. -- 4.2 Detection of Alpha-1 Fetoprotein in Human Serum / Smith, J. B. / Knight, R. A. -- 4.3 Demonstration of Carcinoembryonic Antigens in Tumors of the Gastrointestinal Tract / Kleist, S. von -- 4.4 Radioimmunoassay of CEA: Its Use in Diagnosis and Prognosis of Human Carcinoma / Pusztaszeri, G. / Mach, J.-P. -- 4.5 A Contribution for the Detection of Fetal Antigens in Serum of Tumor Patients / Schultze-Mosgau, H. / Fischer, K. -- 5. Methods for Detection of Proteins Excreted by Tumor Cells -- 5.1 Experiments to Induce Myeloma Protein-Forming Neoplasma in Rodents / Hermann, G. -- 5.2 Immunological Differentiation of Monoclonal Immunoglobulins / Gotz, H. -- 5.3 Lung Neoplasia and Paraproteinemia / Ricci, C. / Baldi, C. / Bonardi, R. -- 6. Some Clinical Aspects -- 6.1 Lymphocyte Transformation in Malignant Diseases. Communication II: Results in Reticuloand Lymphoproliferative Diseases as well as in Carcinomas / Pappas, A. / Scheurlen, P. G. -- 6.2 Immunosuppressive Therapy with Antiiymphocytic Globulin and Tumor Formation / Brendel, W. / Ring, J. -- 6.3 Behaviour of GUARINI Reaction in Children with Hemolymphoblastoses and non Tumoral Diseases / Benso, L. / Nigro, N. / ludicello, P. / Brunet, R. M. / Jacob, R. M. -- References
During the last 20 years it has become increasingly clear that the tumor micro-environment, the tumor stroma with its cellular end extracellular components, plays an crucial role in regulating tumor growth and progression. This book on 'Tumor-associated fibroblasts and their matrix' as part of the series on 'Tumor-Microenvironment' is the first comprehensive discussion of these two main players of the tumor microenvironment. The best experts in this new area of tumor research and therapy review the role of these major components in the tumor stroma in the process of tumor development and progression. They discuss their interaction with other players such as blood vessels and immune cells, and show novel perspectives for tumor therapy. This compilation of excellent contributions of the best known experts in this important field in cancer research and therapy is a must for all scientists engaged in basic and clinical research. Increasing evidence of successful targeting of both cellular and matrix components in tumor therapy renders this book of particular interest for scientists engaged in pharmaceutical industry searching for new components for cancer therapy.